Page last updated: 2024-12-06
flerobuterol
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
flerobuterol: structure given in first source; RN given refers to parent compound [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 71254 |
| CHEMBL ID | 2106772 |
| SCHEMBL ID | 249507 |
| MeSH ID | M0193811 |
Synonyms (43)
| Synonym |
|---|
| flerobuterol |
| 2-(tert-butylamino)-1-(2-fluorophenyl)ethanol |
| f05rr5m463 , |
| flerobuterol [inn] |
| flerobuterolum [inn-latin] |
| flerobuterolum |
| 82101-10-8 |
| unii-f05rr5m463 |
| alpha-((tert-butylamino)methyl)-o-fluorobenzyl alcohol |
| AKOS009231224 |
| 2-(tert-butylamino)-1-(2-fluorophenyl)ethan-1-ol |
| .alpha.-((tert-butylamino)methyl)-o-fluorobenzyl alcohol |
| .alpha.-(((1,1-dimethylethyl)amino)methyl)-2-fluorobenzenemethanol |
| benzenemethanol, .alpha.-(((1,1-dimethylethyl)amino)methyl)-2-fluoro- |
| 101687-92-7 |
| (+/-)-flerobuterol |
| CHEMBL2106772 |
| dl-flerobuterol |
| SCHEMBL249507 |
| Z354445174 |
| DTXSID80868640 |
| (+)-alpha-(((1,1-dimethylethyl)amino)methyl)-2-fluorobenzenemethanol |
| unii-m5q6bn4795 |
| (-)-alpha-(((1,1-dimethylethyl)amino)methyl)-2-fluorobenzenemethanol |
| benzenemethanol, alpha-(((1,1-dimethylethyl)amino)methyl)-2-fluoro-, (-)- |
| benzenemethanol, alpha-(((1,1-dimethylethyl)amino)methyl)-2-fluoro-, (+)- |
| unii-65x4yx7x4f |
| flerobuterol, (-)- |
| 101687-94-9 |
| 65X4YX7X4F , |
| l-flerobuterol |
| d-flerobuterol |
| benzenemethanol, .alpha.-(((1,1-dimethylethyl)amino)methyl)-2-fluoro-, (+)- |
| M5Q6BN4795 , |
| flerobuterol, (+)- |
| benzenemethanol, .alpha.-(((1,1-dimethylethyl)amino)methyl)-2-fluoro-, (-)- |
| 101687-91-6 |
| (+)-.alpha.-(((1,1-dimethylethyl)amino)methyl)-2-fluorobenzenemethanol |
| (+)-flerobuterol |
| (-)-flerobuterol |
| (-)-.alpha.-(((1,1-dimethylethyl)amino)methyl)-2-fluorobenzenemethanol |
| Q27277460 |
| EN300-6492969 |
Research Excerpts
Actions
| Excerpt | Reference | Relevance |
|---|---|---|
| "Flerobuterol did not inhibit the radioligand binding to the other receptors at the highest concentration tested, thus leading to a very high beta adrenergic selectivity." | ( Interactions of flerobuterol, an antidepressant drug candidate, with beta adrenoceptors in the rat brain. Martin, P; Morin, D; Puech, AJ; Tillement, JP; Zini, R, 1991) | 1.35 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 12.94
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.94) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||